Respiratory System Drugs Research
11 comprehensive market analysis studies and research reports on the Respiratory System Drugs sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 108 companies, enriched with industry statistics, insights, and a lot more.
Healthcare
Categories
11 Healthcare Reports
Categories
Filters and Sort
Showing 11 of 11 results in Respiratory System Drugs
Pediatric Asthma Treatment Market
CAGR: 6.23%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Amgen, AstraZeneca, Dr. Reddy’s Laboratories Ltd., Sanofi, Sun Pharmaceuticals Industries
Starting at:$4,750
Inhalable Drugs Market
CAGR: 5.41%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Boehringer Ingelheim, Chiesi Farmaceutici, Novartis, GlaxoSmithKline, AstraZeneca
Starting at:$4,750
Asthma Biologics Market
CAGR: 12.27%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Sanofi, GlaxoSmithKline, Celltrion, AstraZeneca, Novartis
Starting at:$4,750
Chronic Obstructive Pulmonary Disease (COPD) Drugs Market
CAGR: 5.09%
Study Period: 2019 - 2030
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, Teva Pharmaceutical Industries
Starting at:$4,750
Acute Respiratory Distress Syndrome Treatment Market
CAGR: 6.28%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Faron Pharmaceuticals, BioMarck Pharmaceuticals, Medtronic, Koninklijke Philips, GE Healthcare
Starting at:$4,750
Global Hypoxia Treatment Market
CAGR: 3.5%
Study Period: 2019 - 2030
Starting at:$4,750
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Merck, Koninklijke Philips, Fisher & Paykel Healthcare, Resmed, Hamilton Company
Starting at:$4,750
Dyspnea Treatment Market
CAGR: 6.32%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Mayne Pharma, Hikma Pharmaceuticals, Lannett, GlaxoSmithKline, Teva Pharmaceutical Industries
Starting at:$4,750
Idiopathic Pulmonary Fibrosis Market
CAGR: 6.55%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Boehringer Ingelheim, Roche, Horizon Therapeutics, Cipla, FibroGen Inc.
Starting at:$4,750
Bronchitis Treatment Market
CAGR: 5.18%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, Novartis, Pfizer
Starting at:$4,750
Pediatric Respiratory Disease Therapeutics Market
CAGR: 5.6%
Study Period: 2021 - 2030
Starting at:$4,750
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Regeneron Pharmaceuticals, Boehringer Ingelheim, GlaxoSmithKline, Roche, Novartis
Starting at:$4,750
Pulmonary Drugs Market
CAGR: 5.76%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, Roche
Starting at:$4,750
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
